about
Cell Therapy in Patients with Critical Limb IschemiaVAC therapy to promote wound healing after surgical revascularisation for critical lower limb ischaemia.The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs.Upper extremity vein thrombosis: an alert symptom of breast cancer in elderly patients. Experience on personal casuistry and review of the literatureAdult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms.Aterofisiol(®) in carotid plaque evolutionSurgical resection of carotid body paragangliomas: 10 years of experience.Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.Biomarkers in post-reperfusion syndrome after acute lower limb ischaemia.Spinal cord stimulation to achieve wound healing in a primary lower limb critical ischaemia referral centre.Extreme distal bypass to improve wound healing in Buerger's disease.Adjuvant spinal cord stimulation improves wound healing of peripheral tissue loss due to steal syndrome of the hand: clinical challenge treating a difficult case.The Management of Cardiovascular Risk through Epigenetic BiomarkersVAC therapy for the treatment of complex wounds after cardio-thoracic surgery.Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis.Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines.Doxycycline speeds up healing of chronic venous ulcers.Angiosome-targeted revascularisation in diabetic foot ulcers.Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients.Trophic effects of polynucleotides and hyaluronic acid in the healing of venous ulcers of the lower limbs: a clinical study.Guidelines for venous thromboembolism and clinical practice in Italy: a nationwide survey.Male breast cancer manifesting as cephalic vein thrombosis.Axillary vein thrombosis as the first clinical manifestation of inflammatory breast cancer: report of a case.Hyperhomocysteinaemia and chronic venous ulcers.Gene Therapy to prevent thrombosis and anastomotic restenosis after vascular bypass procedures.Breast cancer and venous disease: a retrospective cohort study.Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.Roles and Clinical Applications of Biomarkers in Cardiovascular Disease 2017.Low molecular weight heparin improves healing of chronic venous ulcers especially in the elderly.Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm.Albumin administration prevents the onset of pressure ulcers in intensive care unit patients.Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.Carotid body paragangliomas and matrix metalloproteinases.Resection of Carotid Body Tumors reduces arterial blood pressure. An underestimated neuroendocrine syndrome.The role of matrix metalloproteinases and neutrophil gelatinase-associated lipocalin in central and peripheral arterial aneurysms.A haemodynamic model of the venous network of the lower limbs.Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease.Role of matrix metalloproteinases in non-healing venous ulcers.Concomitant aortic leiomyosarcoma and takayasu arteritis in a 55-year-old male patient.The management of Takayasu's arteritis: personal experience
P50
Q26795443-E111676B-5B2B-40D6-AA16-BCDE22207507Q33461751-8EEDCF3D-230C-4AA5-AFA6-BAE466934E47Q33632742-6676C36F-39E1-4818-AA62-452041A2A2A1Q35051548-A907C76F-5F21-4B40-B244-39908FCE7FB4Q35239944-06308C2E-CF3C-464C-B28D-916226460719Q35896394-7E6FC094-C0BF-47A3-8051-0B514D3084F8Q38152059-7A01F61A-33C2-4120-9E7D-2192B4AE713DQ38369089-8B31EBFE-E9B7-4F80-9E06-B75552D0476BQ39084806-04454BE2-A086-44FC-BA73-FB92D26678D1Q39208811-0B09D880-8509-442A-AB6F-FAF017950603Q39210461-47878AEC-E2F0-418E-97D1-F45113BC0C6EQ39211696-3999362C-F0A8-4EFD-A003-5F44A163FBC8Q41146679-26B70A4B-1917-400D-B2BC-0647B8EB0783Q41736133-5450112C-6AAD-4A51-8931-70B70EE3E61DQ42132165-59DAF905-0188-4946-8D3A-3D7AB555D256Q42224580-42F54A2D-1BA1-4091-BB91-8AA3DF3904DFQ43642111-CC28B0F8-C9C2-4B2C-ACE9-DD195F075667Q43719973-56283A2A-CC21-4F72-8AB1-7AF39306877FQ43934263-CB6366EA-2321-44E9-B4EB-8D4F292D3FBFQ43955211-F2662FF6-5A5A-42C5-BD0B-88C3E8850B3EQ44275202-A5E505B9-E8F1-499D-BEC6-5096CA93F0F4Q44451641-4C3AC664-FB3C-4961-92FC-D657EC6D69E5Q44774421-D26E5811-6087-401A-B178-EC2207677EA4Q44848247-C8F8EC7A-8934-4DC1-A6A2-23D814C0857EQ45865055-38E0E83A-B95C-4417-ACDA-1979AE7F957CQ45956662-13A1ED61-BF49-4D32-8560-90193BF915DCQ46054346-FAD27024-EDFE-4AF6-BBE8-AA3D385EED44Q47116563-E0DF0C19-1267-47D3-ABF6-FE310FB1987CQ47246447-EE4F147E-20B9-4E7A-AF5B-241E5C6CA451Q47674294-910BEE6D-CAD1-4E66-B506-4CCE9E122507Q48019668-F8C8C025-AD7E-4E6B-BAED-0173C4D64CFEQ48881971-36A0D624-D576-4F62-A15A-4DDDC6766C5EQ50802682-CB53A25F-A7F5-4A23-9B56-46C04A2220E8Q50803612-3186C830-3DDE-4F75-B61C-5926E73562F0Q50849329-ECAFBF9D-3D36-4395-BE82-C53FC00CF284Q50865645-2B20D20C-5619-4675-BD5F-F3DCBF0E848CQ50995559-E6E01688-D47C-4302-9ECB-923ECD17A432Q51189922-4F89BC47-B5A3-43A9-A63A-190ABF41EFE1Q54038556-24B6B18D-75A1-454B-B40B-BACF060B64E6Q80355650-A12C9605-4D09-4406-9334-E25DA60A4E84
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefano de Franciscis
@ast
Stefano de Franciscis
@en
Stefano de Franciscis
@es
Stefano de Franciscis
@nl
Stefano de Franciscis
@sl
type
label
Stefano de Franciscis
@ast
Stefano de Franciscis
@en
Stefano de Franciscis
@es
Stefano de Franciscis
@nl
Stefano de Franciscis
@sl
prefLabel
Stefano de Franciscis
@ast
Stefano de Franciscis
@en
Stefano de Franciscis
@es
Stefano de Franciscis
@nl
Stefano de Franciscis
@sl
P106
P1153
22940211100
P21
P31
P496
0000-0001-9365-4609